Phase 1, Dose Escalation Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer.
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Figitumumab (Primary) ; Cisplatin; Gemcitabine; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Pfizer
- 12 Feb 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Actual patient number (45) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.